ZURICH/BERLIN, June 25 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Friday:
ROCHE ROG.S
The U.S. Food and Drug Administration issued an emergency
use authorization (EUA) for the drug Actemra for the treatment
of hospitalized COVID-19 adults and pediatric patients, the
health agency said on Thursday. urn:newsml:reuters.com:*:nL3N2O64HV
CREDIT SUISSE CSGN.S
U.S. investigators who focus on corporate collusion are
examining how global banks handled multibillion-dollar trades
with Bill Hwang's Archegos Capital Management, Bloomberg Law
reported on Thursday. urn:newsml:reuters.com:*:nL3N2O63QK
COMPANY STATEMENTS
* Interroll Holding AG INRN.S said it had received two
large orders from the United States to supplyhorizontal and
vertical crossbelt sorter solutions for five locations, with an
order volume in the lower double-digit million Swiss francs.
INRN.S
* Vifor Pharma VIFN.S said Abbas Hussain was appointed its
new chief executive officer. VIFN.S
ECONOMY
No major Swiss economic data scheduled.
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))